Mufti ST, Baeesa SS, Al-Maghrabi JA. Primary intracranial lymphomas asian. J Neurosurg. 2016;11(3):232–9. https://doi.org/10.4103/1793-5482.145082.

Article  Google Scholar 

Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17(suppl_4):iv1–iv62. https://doi.org/10.1093/neuonc/nov189

Article  Google Scholar 

Ferreri AJ, Reni M, Foppoli M, et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet. 2009;374:1512–20.

Article  CAS  PubMed  Google Scholar 

Gavrilovic IT, Hormigo A, Yahalom J, De Angelis LM, Abrey LE. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006;24(28):4570–4. https://doi.org/10.1200/JCO.2006.06.6910.

Article  CAS  PubMed  Google Scholar 

De Angelis LM, Iwamoto FM. An update on therapy of primary central nervous system lymphoma. Hematol Am Soc Hematol Educ Program. 2006;1:311–6. https://doi.org/10.1182/asheducation-2006.1.311.

Article  Google Scholar 

Ferreri AJ, Batchelor T, Zucca EM. International collaborative group against primary CNS lymphomas. J Clin Oncol. 2003;21:1649–50.

Article  PubMed  Google Scholar 

Bataille B, Delwail V, Menet E, Vandermarco P, Ingrand I, Wager M, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg. 2000;92(2):261–6. https://doi.org/10.3171/jns.2000.92.2.0261.

Article  CAS  PubMed  Google Scholar 

Lai R, Roseblum MK, De Angelis LM. (2002) Primary CNS lymphoma: a whole- brain disease? Neurology;59(10):1557-62https://doi.org/10.1212/01.wnl.0000034256.20173.ea.

Shibamoto Y, Hayabuchi N, Hiratsuka J, Tokumaru S, Shirato H, Sougawa M, Oya N, Uematsu Y, Hiraoka M. Is whole-brain irradiation necessary for primary central nervous system lymphoma? Patterns of recurrence after partial irradiation. Cancer. 2002;97:261. https://doi.org/10.1002/cncr.11035.

Article  Google Scholar 

De Angelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol. 2002;20:4643–8. https://doi.org/10.1200/JCO.2002.11.013.

Article  Google Scholar 

Neuwelt EA, Guastadisegni PE, Vallyay P, et al. Imaging changes and cognitive out come in primary CNS lymphomas after enhanced chemotherapy delivery. Am J Neuroradiol. 2005;26:258–65.

PubMed  PubMed Central  Google Scholar 

Abrey LE, Yahalom J, De Angelis LM. Long term survival in primary central nervous system lymphoma (PCNSL). J Clin Oncol. 1998;16(3):859–63. https://doi.org/10.1200/JCO.1998.16.3.859.

Article  CAS  PubMed  Google Scholar 

Harder H, Holtel H, Bromberg JE, Poortmans P, Haaxama-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ. Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology. 2004;62(4):544–7. https://doi.org/10.1212/WNL.62.4.544.

Article  CAS  PubMed  Google Scholar 

Ghia A, Wolfgang md, Tomé A. ph.d.,* Sayana Thomas, b.s.,* George Cannon, m.d.,* Deepak Khuntia, m.d.,* John S. Kuo, m.d., ph.d.,† and Minesh P. Mehta, m.d.* Departments of *Human Oncology and †Neurological Surgery, University of Wisconsin, Madison, WI. (2007) Distribution of brain Metastases in relation to the Hippocampus: Implications for neurocognitive functional preservation. International Journal of Radiation Oncology.https://doi.org/10.1016/j.ijrobp.2007.02.016

Brown PD, Gondi V,Pugh S, Tome WA, Wefel JS,Armstrong TS,Bovi JA,Robinson C, Konski A,Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA. Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: Phase III Trial NRG oncology CC001. J Clin Oncol. 2020;38(10):1019–29. https://doi.org/10.1200/JCO.19.02767.

Article  PubMed  PubMed Central  Google Scholar 

Abayomi OK. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol. 1996;35(6):659–63. https://doi.org/10.3109/02841869609083995.

Article  CAS  PubMed  Google Scholar 

Barani IJ, Benedict SH, Lin PS. Neural stem cells: implications for the conventional radiotherapy of central nervous system malignancies. Int J Radiat Oncol Biol Phys. 2007;68(2):324–33. https://doi.org/10.1016/j.ijrobp.2007.01.033.

Article  PubMed  Google Scholar 

Wagner H, Ali A, Glantz M, Blakeley A. (2017) Role of Hippocampal-avoidance whole brain radiation therapy (HA-WBRT) in patients with primary CNS lymphoma (PCNSL). Int J Radiat Oncol. 99(2, Supplement). https://doi.org/10.1016/j.ijrobp.2017.06.1617

Tsai PF, Yang CC, Chuang CC, Huang TY, Wu YM, Pai PC, Tseng CK, Wu TH, Shen YL, Lin SY. Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study. Radiat Oncol. 2015. https://doi.org/10.1186/s13014-015-0562-x.

Article  PubMed  PubMed Central  Google Scholar 

Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM,K achnic LA. Pretreatment volume of MRI-determined white matter injury predicts neurocognitive decline after hippocampal avoidant whole-brain radiation therapy for brain metastases: secondary analysis of NRG Oncology Radiation Therapy Oncology Group 0933. Radiat Oncol. 2019;4(4):579–86. https://doi.org/10.1016/j.adro.2019.07.006.

Article  Google Scholar 

Gondi V, Tolakanahalli R, Mehta MP, et al. Hippocampal- sparing whole-brain radiotherapy: a “how-to” technique using helical tomotherapy and linear accelerator-based intensity- modulated radiotherapy. Int J Radiat Oncol Biology Phys. 2010;78:1244–52. https://doi.org/10.1016/j.ijrobp.2010.01.039.

Article  Google Scholar 

Chera BS, Amdur RJ, Patel P, Mendenhall WM. A radiation oncologist’s guide to contouring the hippocampus. Am J Clin Oncol. 2009;32(1):20–2. https://doi.org/10.1097/COC.0b013e318178e4e8.

Article  PubMed  Google Scholar 

Scoville WB, Milner B. Loss of recent memory after bilateral hippocampal lesions. 1957. J Neuropsychiatry Clin Neurosci. 2000;12(1):103–13.https://doi.org/10.1176/jnp.12.1.103-a.

Article  CAS  PubMed  Google Scholar 

Mizumatsu S, Monje ML, Morhardt DR, Rola R, Palmer TD, Fike JR. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003;63(14):4021-7.

CAS  PubMed  Google Scholar 

Raber J, Rola R,LeFevour A, Morhardt D, Curley J, Mizumatsu S, VandenBerg SR, Fike JR. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res. 2004;162(1):39–47. https://doi.org/10.1667/rr3206.

Article  CAS  PubMed  Google Scholar 

Nagai R, Tsunoda S, Hori Y, Asada H. Selective vulnerability to radiation in the hippocampal dentate granule cells. Surg Neurol. 2000;53(5):503–6. https://doi.org/10.1016/s0090-3019(00)00214-7. discussion 506-7.

Article  CAS  PubMed  Google Scholar 

Gondi V, Tome WA, Marsh J, Struck A, Ghia A, Turian JV, Bentzen SM, Kuo JS, Khuntia D, Mehta MP. Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Clin Trial Radiother Oncol. 2010;95(3):327–31. https://doi.org/10.1016/j.radonc.2010.02.030.

Article  Google Scholar 

Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol. 2013;31(31):3971-9. https://doi.org/10.1200/JCO.2013.50.4910.

Article  CAS  PubMed  PubMed Central  Google Scholar